Prognostic value of galectin-3 in primary cutaneous melanoma

Background Galectin‐3, one of the β‐galactoside‐binding lectins, has been suggested as a marker of disease progression in melanoma patients because of its overexpression observed in recent studies. However, prognostic value of galectin‐3 in primary cutaneous melanoma (PCM) has not been clearly defi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2011-10, Vol.25 (10), p.1174-1181
Hauptverfasser:	Buljan, M., Šitum, M., Tomas, D., Milošević, M., Krušlin, B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Biomarkers - metabolism Cohort Studies Disease Progression Female Follow-Up Studies Galectin 3 - metabolism galectin-3 Humans Kaplan-Meier Estimate Male melanoma Melanoma - diagnosis Melanoma - metabolism Melanoma - pathology Middle Aged Prognosis Regression Analysis Retrospective Studies Risk Factors Skin Neoplasms - diagnosis Skin Neoplasms - metabolism Skin Neoplasms - pathology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!